Enrolling by invitationPhase 2NCT05350774

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

Studying Brain inflammatory disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator
Avindra Nath, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Intervention
IV normal saline(drug)
Enrollment
45 target
Eligibility
18-100 years · All sexes
Timeline
20232026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05350774 on ClinicalTrials.gov

Other trials for Brain inflammatory disease

Additional recruiting or active studies for the same condition.

See all trials for Brain inflammatory disease

← Back to all trials